Table 3.

MVA of survival outcomes in patients with inv(16)

Covariate	HR	95% CI	P
inv(16) DFS
Hypodiploidy vs pseudodiploidy	0.532	0.122-2.325	.402
Hyperdiploidy vs pseudodiploidy	0.681	0.339-1.370	.281
Trisomy 8	0.686	0.335-1.406	.303
Presence of secondary chromosomal abnormalities	0.916	0.520-1.613	.762
inv(16) OS
Trisomy 8	0.397	0.184-.854	.018
Other chromosomal abnormalities	2.052	1.186-3.550	.010

All MVAs were adjusted for age, WBC count at diagnosis, and KIT mutation (positive, negative, and not tested).